1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Sarcomatoid Renal Cell Carcinoma: new trials by email Literature Review of Sarcomatoid Renal Cell Carcinoma trials Research Report on Sarcomatoid Renal Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer Bevacizumab, Sorafenib Tosylate, Pharmacological Study - Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 73 | 2005-05-01 | 2015-01-15 |
Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Bevacizumab (1) · Sorafenib (1)
National Cancer Institute (NCI) (1)
United States (1)
Jeffrey Sosman (1)
P30CA068485 (1), U01CA099177 (1)